Yes, all of the decision making that has placed DXB in it's current Position can be attributed to Management (previous and current). Since I have seen Kathy at the Helm , PR and Investor presentations have lifted in professionalism. I've never been in a Normal Biotech yet,, the only thing that's going to turn DXB around is positive data,, I believe they have something and will wait the course to find out. Well done if you were on PAB.
Yes, all of the decision making that has placed DXB in it's...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.3¢ |
Change
-0.018(4.73%) |
Mkt cap ! $25.68M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.3¢ | $404.7K | 1.116M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 149218 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 51186 | 6 |
View Market Depth
| Last trade - 12.31pm 05/12/2024 (20 minute delay) ? |
| DXB (ASX) Chart |